10.6084/m9.figshare.11543391.v1
Ayako Fuchigami
Ayako
Fuchigami
Fumika Shigiyama
Fumika
Shigiyama
Toru Kitazawa
Toru
Kitazawa
Yosuke Okada
Yosuke
Okada
Takamasa Ichijo
Takamasa
Ichijo
Mariko Higa
Mariko
Higa
Toru Hiyoshi
Toru
Hiyoshi
Ikuo Inoue
Ikuo
Inoue
Kaoru Iso
Kaoru
Iso
Hidenori Yoshii
Hidenori
Yoshii
Takahisa Hirose
Takahisa
Hirose
Naoki Kumashiro
Naoki
Kumashiro
MOESM5 of Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
Springer Nature
2020
Type 2 diabetes
Cardiometabolic risk factors
Dapagliflozin
Sitagliptin
Glycemic control
Weight loss
Hypoglycemia
2020-01-08 04:55:41
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/MOESM5_of_Efficacy_of_dapagliflozin_versus_sitagliptin_on_cardiometabolic_risk_factors_in_Japanese_patients_with_type_2_diabetes_a_prospective_randomized_study_DIVERSITY-CVR_/11543391
Additional file 5: Table S4. Adverse events.